These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 15077098
21. Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patients. Serebruany VL, Malinin AI, Atar D. Cardiology; 2007; 107(4):307-12. PubMed ID: 17264511 [Abstract] [Full Text] [Related]
22. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. Motovska Z, Kala P. Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914 [Abstract] [Full Text] [Related]
29. Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort. Szük T, Gyöngyösi M, Homorodi N, Kristóf E, Király C, Edes IF, Facskó A, Pavo N, Sodeck G, Strehblow C, Farhan S, Maurer G, Glogar D, Domanovits H, Huber K, Edes I. Am Heart J; 2007 Feb; 153(2):289-95. PubMed ID: 17239691 [Abstract] [Full Text] [Related]
34. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Circulation; 2004 Sep 07; 110(10):1202-8. PubMed ID: 15313956 [Abstract] [Full Text] [Related]
38. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Lewis BS, Mehta SR, Fox KA, Halon DA, Zhao F, Peters RJ, Keltai M, Budaj A, Yusuf S, CURE trial investigators. Am Heart J; 2005 Dec 28; 150(6):1177-84. PubMed ID: 16338255 [Abstract] [Full Text] [Related]
39. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience. Maegdefessel L, Schlitt A, Faerber J, Bond SP, Messow CM, Buerke M, Raaz U, Werdan K, Muenzel T, Weiss C. Med Klin (Munich); 2008 Sep 15; 103(9):628-32. PubMed ID: 18813885 [Abstract] [Full Text] [Related]
40. Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted? Angiolillo DJ, Fernández-Ortiz A, Bernardo E, Barrera Ramírez C, Sabaté M, Fernandez C, Hernández-Antolín R, Escaned J, Alfonso F, Macaya C. J Invasive Cardiol; 2004 Apr 15; 16(4):169-74. PubMed ID: 15152138 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]